K-Line Chart, actual market data is subject to the trading page.
Key Data
Prev. Open
$24.28
Prev. Close
$24.47
Prev. Day's Range
$24.23 - $24.72
52W Range
$21.97 - $28.28
Trading Volume
31.756M
MC
$137.756B
P/E Ratio
18.4x
EPS
$1.31
Company Overview
NYSE
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The name of the company commemorates its co-founder, Charles Pfizer (1824-1906). Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company has several blockbuster drugs or products that each generate more than 1 billion USD in annual revenues.
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - GENERAL
Headquarters66 HUDSON BOULEVARD EAST, NEW YORK, NY, UNITED STATES, 10001-2192
Pfizer Inc. (PFE) is a global biopharmaceutical company that specializes in developing, manufacturing, and distributing a wide range of medicines, vaccines, and healthcare products. Its portfolio includes treatments for conditions such as infectious diseases, oncology, and immunology. The company is also known for its strong presence in vaccine innovation.
Pfizer operates in the Healthcare sector and falls within the Pharmaceuticals industry. This industry focuses on drug research, development, and manufacturing to address medical conditions and improve global health.
Pfizer's main revenue drivers are its vaccines, healthcare products, and prescription medicines, including their COVID-19 vaccine and antiviral treatments. Additionally, its focus on oncology, rare diseases, and immunology contributes significantly to its revenue streams.
Yes, Pfizer is known for paying regular dividends to its shareholders. The company has a history of maintaining consistent dividend payouts, which can make it appealing to income-focused investors. However, investors should review the dividend yield and payout history as part of their research.
Investors should consider risks such as patent expirations for high-revenue drugs, regulatory hurdles, competition from generic drug manufacturers, and the potential for fluctuating demand for its COVID-related products. Broader market conditions and healthcare policy changes can also impact Pfizer’s performance.
Pfizer faces competition from other major pharmaceutical companies such as Johnson & Johnson, Merck & Co., Moderna, and Roche. These companies also operate in areas like vaccines, oncology, and general medicine, making the competitive landscape dynamic and challenging.
Pfizer has played a significant role in global healthcare, particularly with the development and distribution of its COVID-19 vaccine in partnership with BioNTech. Additionally, its research pipeline continues to address critical areas such as oncology, rare diseases, and infectious diseases.
Key factors include the success of its drug pipeline, demand for its COVID-19 treatments, regulatory approvals, and competition from other pharmaceutical companies. Broader economic conditions, healthcare reforms, and currency fluctuations may also affect its performance.
Risk Warning
1.Stock prices may fluctuate significantly; invest with caution. Past performance is not indicative of future results.
2.Digital asset trading involves multiple risks, including market and technical risks. Please make rational decisions and allocate assets wisely.
3.The information contained on this page is for reference only and does not constitute any investment advice.
